MacDonald, Tracy C.; Korbas, Malgorzata; James, Ashley K.; Sylvain, Nicole J.; Hackett, Mark J. et al. (2015). Interaction of mercury and selenium in the larval stage zebrafish vertebrate model. Metallomics 7(8) , 1247-1255. 10.1039/c5mt00145e. |
CLS-APS |
Peer-Reviewed Article |
Health |
Koch, Iris; Zhang, Jing; Button, Mark; Gibson, Laura A.; Caumette, Guilhem et al. (2015). Arsenic(+3) and DNA methyltransferases, and arsenic speciation in tadpole and frog life stages of western clawed frogs (Silurana tropicalis) exposed to arsenate. Metallomics 7(8) , 1274-1284. 10.1039/c5mt00078e. |
CLS-APS |
Peer-Reviewed Article |
Health |
Koch, Iris; Moriarty, Maeve; Sui, Jie; Rutter, Allison; Saper, Robert B. et al. (2013). Bioaccessibility of mercury in selected Ayurvedic medicines. Science of the Total Environment 454-455, 9-15. 10.1016/j.scitotenv.2013.02.089. |
CLS-APS |
Peer-Reviewed Article |
Health |
Prince, Lisa; Korbas, Malgorzata; Davidson, Philip; Broberg, Karin; Rand, Matthew Dearborn et al. (2014). Target Organ Specific Activity of Drosophila MRP (ABCC1) Moderates Developmental Toxicity of Methylmercury. Toxicological Sciences 140(2) , 425-435. 10.1093/toxsci/kfu095. |
CLS-APS |
Peer-Reviewed Article |
Health |
Korbas, Malgorzata; MacDonald, Tracy C.; Pickering, Ingrid J.; George, Graham N.; Krone, Patrick H. et al. (2011). Chemical Form Matters: Differential Accumulation of Mercury Following Inorganic and Organic Mercury Exposures in Zebrafish Larvae. ACS Chemical Biology 7(2) , 411-420. 10.1021/cb200287c. |
CLS-APS |
Peer-Reviewed Article |
Health |
Ball, Katherine R.; Sampieri, Francesca; Chirino, Manuel; Hamilton, Don L.; Blyth, Robert I. R. et al. (2013). Synchrotron X-Ray Fluorescence Microscopy of Gallium in Bladder Tissue following Gallium Maltolate Administration during Urinary Tract Infection. Antimicrobial Agents and Chemotherapy 57(11) , 5197-5201. 10.1128/aac.00616-13. |
CLS-APS |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Powder pattern and hydrogen bonding in the crystal structure of phenelzine sulfate, C
8
H
14
N
2
(SO
4
). Powder Diffraction , 1-5. 10.1017/s0885715625000545. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of repotrectinib, C18H18FN5O2. Powder Diffraction , 1-6. 10.1017/s0885715625100882. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of palovarotene, C
27
H
30
N
2
O
2
. Powder Diffraction , 1-6. 10.1017/s0885715625100869. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of niraparib tosylate monohydrate Form I, (C
19
H
21
N
4
O)(C
7
H
7
O
3
S)(H
2
O). Powder Diffraction , 1-9. 10.1017/s0885715625000181. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2025). Crystal structure of iprodione, C13H13Cl2N3O3. Powder Diffraction , 1-5. 10.1017/s0885715625100742. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of givinostat hydrochloride monohydrate Form I, C
24
H
28
N
3
O
4
Cl(H
2
O). Powder Diffraction , 1-6. 10.1017/s0885715625100559. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of ethynodiol diacetate, C
24
H
32
O
4
. Powder Diffraction , 1-6. 10.1017/s0885715625100729. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James; Dosen, Anja; Blanton, Tom (2025). Crystal structure of anisomycin, C
14
H
19
NO
4
. Powder Diffraction , 1-6. 10.1017/s0885715625100791. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). A proposed crystal structure of fruquintinib Form I, C21H19N3O5. Powder Diffraction , 1-7. 10.1017/s0885715625100808. |
BXDS-WLE |
Peer-Reviewed Article |
Health |